Barclays’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $67.3M | Sell |
999,563
-124,771
| -11% | -$8.31M | 0.01% | 626 |
|
|
2026
Q1 | $70.6M | Sell |
1,124,334
-215,122
| -16% | -$15M | 0.02% | 614 |
|
|
2025
Q4 | $88.9M | Sell |
1,339,456
-229,025
| -15% | -$14.8M | 0.02% | 547 |
|
|
2025
Q3 | $106M | Buy |
1,568,481
+118,547
| +8% | +$9.38M | 0.02% | 475 |
|
|
2025
Q2 | $127M | Buy |
1,449,934
+870
| +0.1% | +$68.2K | 0.03% | 396 |
|
|
2025
Q1 | $99M | Buy |
1,449,064
+179,978
| +14% | +$14.7M | 0.03% | 423 |
|
|
2024
Q4 | $98.7M | Buy |
1,269,086
+63,240
| +5% | +$4.68M | 0.03% | 411 |
|
|
2024
Q3 | $80.8M | Sell |
1,205,846
-249,627
| -17% | -$20.5M | 0.02% | 506 |
|
|
2024
Q2 | $165M | Buy |
1,455,473
+174,646
| +14% | +$22.1M | 0.05% | 270 |
|
|
2024
Q1 | $178M | Buy |
1,280,827
+170,755
| +15% | +$21.5M | 0.06% | 253 |
|
|
2023
Q4 | $138M | Buy |
1,110,072
+88,500
| +9% | +$9.04M | 0.05% | 319 |
|
|
2023
Q3 | $95.3M | Buy |
1,021,572
+226,783
| +29% | +$25.6M | 0.06% | 324 |
|
|
2023
Q2 | $102M | Buy |
794,789
+374,840
| +89% | +$45.3M | 0.06% | 269 |
|
|
2023
Q1 | $48.8M | Sell |
419,949
-173,975
| -29% | -$19.5M | 0.02% | 473 |
|
|
2022
Q4 | $67.3M | Buy |
593,924
+141,639
| +31% | +$15.6M | 0.03% | 369 |
|
|
2022
Q3 | $36.4M | Buy |
452,285
+73,084
| +19% | +$6.19M | 0.04% | 404 |
|
|
2022
Q2 | $28.3M | Sell |
379,201
-228,983
| -38% | -$20.9M | 0.02% | 577 |
|
|
2022
Q1 | $77.8M | Sell |
608,184
-159,992
| -21% | -$17.5M | 0.06% | 293 |
|
|
2021
Q4 | $103M | Buy |
768,176
+13,080
| +2% | +$1.88M | 0.04% | 339 |
|
|
2021
Q3 | $103M | Buy |
755,096
+163,936
| +28% | +$20.7M | 0.05% | 308 |
|
|
2021
Q2 | $63.1M | Buy |
591,160
+61,724
| +12% | +$5.93M | 0.03% | 427 |
|
|
2021
Q1 | $47.6M | Sell |
529,436
-146,924
| -22% | -$13.8M | 0.03% | 466 |
|
|
2020
Q4 | $62.5M | Buy |
676,360
+197,940
| +41% | +$17.7M | 0.03% | 389 |
|
|
2020
Q3 | $49.3M | Buy |
478,420
+104,908
| +28% | +$11M | 0.03% | 400 |
|
|
2020
Q2 | $37.9M | Buy |
373,512
+244,224
| +189% | +$21.8M | 0.03% | 404 |
|
|
2020
Q1 | $8.7M | Sell |
129,288
-9,452
| -7% | -$588K | 0.01% | 1077 |
|
|
2019
Q4 | $7.59M | Sell |
138,740
-16,244
| -10% | -$770K | ﹤0.01% | 1607 |
|
|
2019
Q3 | $5.78M | Sell |
154,984
-1,009,716
| -87% | -$39.2M | ﹤0.01% | 1719 |
|
|
2019
Q2 | $43.6M | Buy |
1,164,700
+1,000,392
| +609% | +$31.4M | 0.03% | 536 |
|
|
2019
Q1 | $4.89M | Sell |
164,308
-21,060
| -11% | -$740K | ﹤0.01% | 1680 |
|
|
2018
Q4 | $5.55M | Sell |
185,368
-77,340
| -29% | -$2.45M | ﹤0.01% | 1522 |
|
|
2018
Q3 | $9.39M | Buy |
262,708
+36,512
| +16% | +$1.13M | 0.01% | 1302 |
|
|
2018
Q2 | $5.37M | Buy |
226,196
+156,892
| +226% | +$3.33M | ﹤0.01% | 1670 |
|
|
2018
Q1 | $1.28M | Sell |
69,304
-40,660
| -37% | -$601K | ﹤0.01% | 2922 |
|
|
2017
Q4 | $1.58M | Buy |
109,964
+76,540
| +229% | +$995K | ﹤0.01% | 2667 |
|
|
2017
Q3 | $409K | Sell |
33,424
-49,432
| -60% | -$874K | ﹤0.01% | 3808 |
|
|
2017
Q2 | $1.51M | Buy |
82,856
+32,104
| +63% | +$593K | ﹤0.01% | 2500 |
|
|
2017
Q1 | $1.07M | Sell |
50,752
-72,116
| -59% | -$1.41M | ﹤0.01% | 2667 |
|
|
2016
Q4 | $1.83M | Buy |
122,868
+86,064
| +234% | +$1.52M | ﹤0.01% | 2201 |
|
|
2016
Q3 | $806K | Sell |
36,804
-52,828
| -59% | -$1.18M | ﹤0.01% | 2827 |
|
|
2016
Q2 | $1.78M | Buy |
89,632
+72,956
| +437% | +$1.24M | ﹤0.01% | 2113 |
|
|
2016
Q1 | $279K | Sell |
16,676
-30,984
| -65% | -$518K | ﹤0.01% | 3607 |
|
|
2015
Q4 | $965K | Buy |
47,660
+21,924
| +85% | +$456K | ﹤0.01% | 2644 |
|
|
2015
Q3 | $547K | Buy |
25,736
+20,692
| +410% | +$462K | ﹤0.01% | 3272 |
|
|
2015
Q2 | $100K | Sell |
5,044
-3,956
| -44% | -$69.5K | ﹤0.01% | 4670 |
|
|
2015
Q1 | $140K | Sell |
9,000
-212,344
| -96% | -$3.21M | ﹤0.01% | 4609 |
|
|
2014
Q4 | $3.04M | Buy |
221,344
+210,972
| +2,034% | +$2.58M | ﹤0.01% | 2150 |
|
|
2014
Q3 | $101K | Buy |
10,372
+2,084
| +25% | +$21.3K | ﹤0.01% | 5314 |
|
|
2014
Q2 | $80K | Sell |
8,288
-3,708
| -31% | -$32.9K | ﹤0.01% | 5587 |
|
|
2014
Q1 | $122K | Sell |
11,996
-44,824
| -79% | -$463K | ﹤0.01% | 5266 |
|
|
2013
Q4 | $498K | Buy |
56,820
+13,080
| +30% | +$104K | ﹤0.01% | 4100 |
|
|
2013
Q3 | $306K | Buy |
43,740
+28,704
| +191% | +$182K | ﹤0.01% | 4614 |
|
|
2013
Q2 | $84K | Buy |
+15,036
| New | +$72K | ﹤0.01% | 5918 |
|
Other funds holding DXCM
Barclays's DXCM Position: Q2 2026 in Review
Barclays reduced its DexCom (DXCM) stake by 11% in Q2 2026, selling an estimated $8.31M and leaving 999,563 shares worth $67.3M. The position accounts for 0.01% of the portfolio, ranked #626.
Barclays first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $178M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Barclays held 999,563 shares of DexCom worth $67.3M as of Q2 2026.
- Barclays sold 124,771 DexCom shares in Q2 2026, an estimated $8.31M.
- DexCom made up 0.01% of Barclays's portfolio in Q2 2026, its #626 holding.
- Barclays first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
- Barclays's DexCom position peaked at $178M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.